Report Detail

Pharma & Healthcare Global Acamprosate Calcium Market Insights, Forecast to 2025

  • RnM3518057
  • |
  • 12 June, 2019
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Study Coverage

    • 1.1 Acamprosate Calcium Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Acamprosate Calcium Market Size Growth Rate by Product
      • 1.4.2 333 mg Delayed Release Tablet
      • 1.4.3 Type II
    • 1.5 Market by End User
      • 1.5.1 Global Acamprosate Calcium Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Drug store
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Acamprosate Calcium Market Size
      • 2.1.1 Global Acamprosate Calcium Revenue 2014-2025
      • 2.1.2 Global Acamprosate Calcium Sales 2014-2025
    • 2.2 Acamprosate Calcium Growth Rate by Regions
      • 2.2.1 Global Acamprosate Calcium Sales by Regions
      • 2.2.2 Global Acamprosate Calcium Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Acamprosate Calcium Sales by Manufacturers
      • 3.1.1 Acamprosate Calcium Sales by Manufacturers
      • 3.1.2 Acamprosate Calcium Sales Market Share by Manufacturers
      • 3.1.3 Global Acamprosate Calcium Market Concentration Ratio (CR5 and HHI)
    • 3.2 Acamprosate Calcium Revenue by Manufacturers
      • 3.2.1 Acamprosate Calcium Revenue by Manufacturers (2014-2019)
      • 3.2.2 Acamprosate Calcium Revenue Share by Manufacturers (2014-2019)
    • 3.3 Acamprosate Calcium Price by Manufacturers
    • 3.4 Acamprosate Calcium Manufacturing Base Distribution, Product Types
      • 3.4.1 Acamprosate Calcium Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Acamprosate Calcium Product Type
      • 3.4.3 Date of International Manufacturers Enter into Acamprosate Calcium Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Acamprosate Calcium Sales by Product
    • 4.2 Global Acamprosate Calcium Revenue by Product
    • 4.3 Acamprosate Calcium Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Acamprosate Calcium Breakdown Data by End User

    6 North America

    • 6.1 North America Acamprosate Calcium by Countries
      • 6.1.1 North America Acamprosate Calcium Sales by Countries
      • 6.1.2 North America Acamprosate Calcium Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Acamprosate Calcium by Product
    • 6.3 North America Acamprosate Calcium by End User

    7 Europe

    • 7.1 Europe Acamprosate Calcium by Countries
      • 7.1.1 Europe Acamprosate Calcium Sales by Countries
      • 7.1.2 Europe Acamprosate Calcium Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Acamprosate Calcium by Product
    • 7.3 Europe Acamprosate Calcium by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Acamprosate Calcium by Countries
      • 8.1.1 Asia Pacific Acamprosate Calcium Sales by Countries
      • 8.1.2 Asia Pacific Acamprosate Calcium Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Acamprosate Calcium by Product
    • 8.3 Asia Pacific Acamprosate Calcium by End User

    9 Central & South America

    • 9.1 Central & South America Acamprosate Calcium by Countries
      • 9.1.1 Central & South America Acamprosate Calcium Sales by Countries
      • 9.1.2 Central & South America Acamprosate Calcium Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Acamprosate Calcium by Product
    • 9.3 Central & South America Acamprosate Calcium by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Acamprosate Calcium by Countries
      • 10.1.1 Middle East and Africa Acamprosate Calcium Sales by Countries
      • 10.1.2 Middle East and Africa Acamprosate Calcium Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Acamprosate Calcium by Product
    • 10.3 Middle East and Africa Acamprosate Calcium by End User

    11 Company Profiles

    • 11.1 Merck Group
      • 11.1.1 Merck Group Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Merck Group Acamprosate Calcium Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Merck Group Acamprosate Calcium Products Offered
      • 11.1.5 Merck Group Recent Development
    • 11.2 Zydus Pharmaceuticals
      • 11.2.1 Zydus Pharmaceuticals Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Zydus Pharmaceuticals Acamprosate Calcium Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Zydus Pharmaceuticals Acamprosate Calcium Products Offered
      • 11.2.5 Zydus Pharmaceuticals Recent Development
    • 11.3 Mylan
      • 11.3.1 Mylan Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Mylan Acamprosate Calcium Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Mylan Acamprosate Calcium Products Offered
      • 11.3.5 Mylan Recent Development
    • 11.4 Teva
      • 11.4.1 Teva Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Teva Acamprosate Calcium Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Teva Acamprosate Calcium Products Offered
      • 11.4.5 Teva Recent Development
    • 11.5 Glenmark Pharmaceuticals
      • 11.5.1 Glenmark Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Glenmark Pharmaceuticals Acamprosate Calcium Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Glenmark Pharmaceuticals Acamprosate Calcium Products Offered
      • 11.5.5 Glenmark Pharmaceuticals Recent Development

    12 Future Forecast

    • 12.1 Acamprosate Calcium Market Forecast by Regions
      • 12.1.1 Global Acamprosate Calcium Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Acamprosate Calcium Revenue Forecast by Regions 2019-2025
    • 12.2 Acamprosate Calcium Market Forecast by Product
      • 12.2.1 Global Acamprosate Calcium Sales Forecast by Product 2019-2025
      • 12.2.2 Global Acamprosate Calcium Revenue Forecast by Product 2019-2025
    • 12.3 Acamprosate Calcium Market Forecast by End User
    • 12.4 North America Acamprosate Calcium Forecast
    • 12.5 Europe Acamprosate Calcium Forecast
    • 12.6 Asia Pacific Acamprosate Calcium Forecast
    • 12.7 Central & South America Acamprosate Calcium Forecast
    • 12.8 Middle East and Africa Acamprosate Calcium Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Acamprosate Calcium Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support.
      The global Acamprosate Calcium market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acamprosate Calcium market based on company, product type, end user and key regions.

      This report studies the global market size of Acamprosate Calcium in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acamprosate Calcium in these regions.
      This research report categorizes the global Acamprosate Calcium market by top players/brands, region, type and end user. This report also studies the global Acamprosate Calcium market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Merck Group
      Zydus Pharmaceuticals
      Mylan
      Teva
      Glenmark Pharmaceuticals

      Market size by Product
      333 mg Delayed Release Tablet
      Type II
      Market size by End User
      Hospital
      Drug store

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Acamprosate Calcium market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Acamprosate Calcium market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Acamprosate Calcium companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Acamprosate Calcium submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Acamprosate Calcium are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acamprosate Calcium market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Acamprosate Calcium . Industry analysis & Market Report on Acamprosate Calcium is a syndicated market report, published as Global Acamprosate Calcium Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Acamprosate Calcium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      2,968.45
      4,452.67
      5,936.90
      3,519.43
      5,279.14
      7,038.85
      423,657.00
      635,485.50
      847,314.00
      277,984.59
      416,976.88
      555,969.18
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report